4BB — 4Basebio Cashflow Statement
0.000.00%
Last trade - 00:00- £110.71m
- £100.04m
- £0.93m
Annual cashflow statement for 4Basebio, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.719 | -3.23 | -5.15 | -7.67 | -12.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.122 | -0.28 | -0.554 | -0.167 | 0.056 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.702 | 0.455 | 0.569 | 0.945 | 0.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.02 | -2.74 | -4.7 | -6.18 | -10.7 |
| Capital Expenditures | -0.849 | -1.51 | -1.94 | -1.49 | -1.57 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.29 | 0 | — | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | 1.45 | -1.51 | -1.94 | -1.49 | -1.57 |
| Financing Cash Flow Items | 14.5 | -0.407 | 1.32 | 6.52 | 4.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.4 | -0.467 | 1.24 | 6.42 | 43.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.9 | -5.42 | -5.24 | -1.28 | 31.5 |